US Stock MarketDetailed Quotes

CRXM Gene Biotherapeutics

Watchlist
  • 0.000001
  • 0.0000000.00%
15min DelayClose Feb 9 16:00 ET
64.93Market Cap0.00P/E (TTM)

Gene Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
(Q1)Mar 31, 2017
Assets
Current assets
Cash, cash equivalents and short term investments
96,406.75%386.03K
96,406.75%386.03K
--781.57K
--1.31M
--2.93K
-99.51%400
--400
67.62%82.12K
-94.73%48.99K
47.87%176.37K
-Cash and cash equivalents
96,406.75%386.03K
96,406.75%386.03K
--781.57K
--1.31M
--2.93K
-99.51%400
--400
67.62%82.12K
-94.73%48.99K
47.87%176.37K
Prepaid assets
-24.03%24.61K
-24.03%24.61K
--19.17K
--20.42K
--111.99K
70.81%32.4K
--32.4K
-24.14%18.97K
139.79%25K
324.70%39.2K
Total current assets
1,152.13%410.64K
1,152.13%410.64K
--800.75K
--1.33M
--114.91K
-67.56%32.8K
--32.8K
36.61%101.08K
-92.14%73.99K
67.75%215.57K
Non current assets
Net PPE
5,554.20%149.27K
5,554.20%149.27K
--167K
--1.85K
--2.22K
-95.66%2.64K
--2.64K
-50.96%60.82K
-21.62%124.02K
4,393.87%146.59K
-Gross PPE
72.91%352.05K
72.91%352.05K
--369.12K
--203.61K
--203.61K
0.00%203.61K
--203.61K
0.00%203.61K
18.56%203.61K
----
-Accumulated depreciation
-0.90%-202.78K
-0.90%-202.78K
---202.13K
---201.76K
---201.39K
-40.74%-200.97K
---200.97K
-79.41%-142.79K
-489.50%-79.59K
----
Other non current assets
--7.07K
--7.07K
--7.07K
--7.09K
--12.54K
----
----
----
0.00%11.77K
--11.77K
Total non current assets
5,822.16%156.35K
5,822.16%156.35K
--174.07K
--8.94K
--14.76K
-95.66%2.64K
--2.64K
-55.21%60.82K
-20.12%135.78K
4,754.60%158.36K
Total assets
1,500.06%566.98K
1,500.06%566.98K
--974.82K
--1.34M
--129.67K
-78.11%35.44K
--35.44K
-22.82%161.9K
-81.12%209.77K
183.78%373.93K
Liabilities
Current liabilities
Payables
-22.91%745.57K
-22.91%745.57K
--661.95K
--821.67K
--1.04M
-47.95%967.13K
--967.13K
-0.66%1.86M
11.79%1.87M
-5.53%2.65M
-accounts payable
-22.91%745.57K
-22.91%745.57K
--661.95K
--821.67K
--1.04M
-47.95%967.13K
--967.13K
-0.66%1.86M
11.79%1.87M
-8.87%1.61M
-Due to related parties current
----
----
----
----
----
----
----
----
----
0.10%1.05M
Current accrued expenses
11.89%3.13M
11.89%3.13M
--3.06M
--2.98M
--2.89M
-2.10%2.8M
--2.8M
27.27%2.86M
34.37%2.24M
74.18%658.21K
Current debt and capital lease obligation
15.35%1.15M
15.35%1.15M
--1.21M
--941.1K
--972.03K
-6.26%999.17K
--999.17K
-13.43%1.07M
17.23%1.23M
----
-Current debt
8.50%1.08M
8.50%1.08M
--1.14M
--941.1K
--972.03K
-6.26%999.17K
--999.17K
-13.43%1.07M
17.23%1.23M
----
-Current capital lease obligation
--68.45K
--68.45K
--66.96K
----
----
--0
--0
----
----
----
Current deferred liabilities
----
----
----
----
----
----
----
6.75%10.27K
--9.62K
----
Other current liabilities
----
----
----
---2
----
----
----
----
----
----
Current liabilities
5.55%5.03M
5.55%5.03M
--4.93M
--4.74M
--4.9M
-17.75%4.76M
--4.76M
8.12%5.79M
21.90%5.36M
5.76%4.31M
Non current liabilities
Long term debt and capital lease obligation
-11.72%107.89K
-11.72%107.89K
--126.85K
--274.59K
--245.74K
--122.21K
--122.21K
----
----
----
-Long term debt
-78.55%26.21K
-78.55%26.21K
--25.66K
--274.59K
--245.74K
--122.21K
--122.21K
----
----
----
-Long term capital lease obligation
--81.68K
--81.68K
--101.18K
----
----
--0
--0
----
----
----
Non current deferred liabilities
----
----
----
----
----
----
----
--0
49.05%10.27K
--6.89K
Total non current liabilities
-11.72%107.89K
-11.72%107.89K
--126.85K
--274.59K
--245.74K
--122.21K
--122.21K
--0
49.05%10.27K
--6.89K
Total liabilities
5.12%5.14M
5.12%5.14M
--5.05M
--5.02M
--5.15M
-15.64%4.89M
--4.89M
7.92%5.79M
21.94%5.37M
5.93%4.32M
Shareholders'equity
Share capital
190.06%4.2K
190.06%4.2K
--3.28K
--1.84K
--1.45K
0.35%1.45K
--1.45K
0.42%1.44K
4.73%1.44K
-99.43%1.43K
-common stock
178.33%4.03K
178.33%4.03K
--3.11K
--1.67K
--1.45K
0.35%1.45K
--1.45K
0.42%1.44K
4.73%1.44K
8.19%1.43K
-Preferred stock
--170
--170
--170
--170
----
--0
--0
--0
--0
--0
Retained earnings
-0.44%-119.43M
-0.44%-119.43M
---118.99M
---118.63M
---119.06M
0.72%-118.91M
---118.91M
-0.36%-119.78M
-1.61%-119.34M
-2.11%-118.03M
Paid-in capital
1.34%115.55M
1.34%115.55M
--115.55M
--115.55M
--114.02M
-0.00%114.02M
--114.02M
0.07%114.02M
0.20%113.94M
2.64%113.71M
Other equity interest
----
----
----
----
--600K
0.00%600K
--600K
0.00%600K
0.00%600K
0.00%600K
Total stockholders'equity
9.68%-3.88M
9.68%-3.88M
---3.43M
---3.07M
---4.44M
16.81%-4.29M
---4.29M
-7.39%-5.16M
-53.03%-4.8M
5.76%-3.72M
Noncontrolling interests
-23.89%-693.16K
-23.89%-693.16K
---646.44K
---606.17K
---578.55K
-18.55%-559.5K
---559.5K
-33.29%-471.96K
-133.37%-354.09K
---226.89K
Total equity
5.81%-4.57M
5.81%-4.57M
---4.08M
---3.68M
---5.02M
13.84%-4.85M
---4.85M
-9.17%-5.63M
-56.74%-5.16M
0.01%-3.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017(Q1)Mar 31, 2017
Assets
Current assets
Cash, cash equivalents and short term investments 96,406.75%386.03K96,406.75%386.03K--781.57K--1.31M--2.93K-99.51%400--40067.62%82.12K-94.73%48.99K47.87%176.37K
-Cash and cash equivalents 96,406.75%386.03K96,406.75%386.03K--781.57K--1.31M--2.93K-99.51%400--40067.62%82.12K-94.73%48.99K47.87%176.37K
Prepaid assets -24.03%24.61K-24.03%24.61K--19.17K--20.42K--111.99K70.81%32.4K--32.4K-24.14%18.97K139.79%25K324.70%39.2K
Total current assets 1,152.13%410.64K1,152.13%410.64K--800.75K--1.33M--114.91K-67.56%32.8K--32.8K36.61%101.08K-92.14%73.99K67.75%215.57K
Non current assets
Net PPE 5,554.20%149.27K5,554.20%149.27K--167K--1.85K--2.22K-95.66%2.64K--2.64K-50.96%60.82K-21.62%124.02K4,393.87%146.59K
-Gross PPE 72.91%352.05K72.91%352.05K--369.12K--203.61K--203.61K0.00%203.61K--203.61K0.00%203.61K18.56%203.61K----
-Accumulated depreciation -0.90%-202.78K-0.90%-202.78K---202.13K---201.76K---201.39K-40.74%-200.97K---200.97K-79.41%-142.79K-489.50%-79.59K----
Other non current assets --7.07K--7.07K--7.07K--7.09K--12.54K------------0.00%11.77K--11.77K
Total non current assets 5,822.16%156.35K5,822.16%156.35K--174.07K--8.94K--14.76K-95.66%2.64K--2.64K-55.21%60.82K-20.12%135.78K4,754.60%158.36K
Total assets 1,500.06%566.98K1,500.06%566.98K--974.82K--1.34M--129.67K-78.11%35.44K--35.44K-22.82%161.9K-81.12%209.77K183.78%373.93K
Liabilities
Current liabilities
Payables -22.91%745.57K-22.91%745.57K--661.95K--821.67K--1.04M-47.95%967.13K--967.13K-0.66%1.86M11.79%1.87M-5.53%2.65M
-accounts payable -22.91%745.57K-22.91%745.57K--661.95K--821.67K--1.04M-47.95%967.13K--967.13K-0.66%1.86M11.79%1.87M-8.87%1.61M
-Due to related parties current ------------------------------------0.10%1.05M
Current accrued expenses 11.89%3.13M11.89%3.13M--3.06M--2.98M--2.89M-2.10%2.8M--2.8M27.27%2.86M34.37%2.24M74.18%658.21K
Current debt and capital lease obligation 15.35%1.15M15.35%1.15M--1.21M--941.1K--972.03K-6.26%999.17K--999.17K-13.43%1.07M17.23%1.23M----
-Current debt 8.50%1.08M8.50%1.08M--1.14M--941.1K--972.03K-6.26%999.17K--999.17K-13.43%1.07M17.23%1.23M----
-Current capital lease obligation --68.45K--68.45K--66.96K----------0--0------------
Current deferred liabilities ----------------------------6.75%10.27K--9.62K----
Other current liabilities ---------------2------------------------
Current liabilities 5.55%5.03M5.55%5.03M--4.93M--4.74M--4.9M-17.75%4.76M--4.76M8.12%5.79M21.90%5.36M5.76%4.31M
Non current liabilities
Long term debt and capital lease obligation -11.72%107.89K-11.72%107.89K--126.85K--274.59K--245.74K--122.21K--122.21K------------
-Long term debt -78.55%26.21K-78.55%26.21K--25.66K--274.59K--245.74K--122.21K--122.21K------------
-Long term capital lease obligation --81.68K--81.68K--101.18K----------0--0------------
Non current deferred liabilities ------------------------------049.05%10.27K--6.89K
Total non current liabilities -11.72%107.89K-11.72%107.89K--126.85K--274.59K--245.74K--122.21K--122.21K--049.05%10.27K--6.89K
Total liabilities 5.12%5.14M5.12%5.14M--5.05M--5.02M--5.15M-15.64%4.89M--4.89M7.92%5.79M21.94%5.37M5.93%4.32M
Shareholders'equity
Share capital 190.06%4.2K190.06%4.2K--3.28K--1.84K--1.45K0.35%1.45K--1.45K0.42%1.44K4.73%1.44K-99.43%1.43K
-common stock 178.33%4.03K178.33%4.03K--3.11K--1.67K--1.45K0.35%1.45K--1.45K0.42%1.44K4.73%1.44K8.19%1.43K
-Preferred stock --170--170--170--170------0--0--0--0--0
Retained earnings -0.44%-119.43M-0.44%-119.43M---118.99M---118.63M---119.06M0.72%-118.91M---118.91M-0.36%-119.78M-1.61%-119.34M-2.11%-118.03M
Paid-in capital 1.34%115.55M1.34%115.55M--115.55M--115.55M--114.02M-0.00%114.02M--114.02M0.07%114.02M0.20%113.94M2.64%113.71M
Other equity interest ------------------600K0.00%600K--600K0.00%600K0.00%600K0.00%600K
Total stockholders'equity 9.68%-3.88M9.68%-3.88M---3.43M---3.07M---4.44M16.81%-4.29M---4.29M-7.39%-5.16M-53.03%-4.8M5.76%-3.72M
Noncontrolling interests -23.89%-693.16K-23.89%-693.16K---646.44K---606.17K---578.55K-18.55%-559.5K---559.5K-33.29%-471.96K-133.37%-354.09K---226.89K
Total equity 5.81%-4.57M5.81%-4.57M---4.08M---3.68M---5.02M13.84%-4.85M---4.85M-9.17%-5.63M-56.74%-5.16M0.01%-3.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg